DIA Biosimilars 2013

Valeant

Novartis to sell Elidel to Meda

Friday, April 8, 2011 10:56 AM

Switzerland-based Novartis will sell the global rights to manufacture and market Elidel skin cream to Meda Pharmaceuticals, based in Sweden, for an upfront payment of $420 million, according to a Bloomberg report.

More... »

Cenduit: Now with Patient Reminders

Cephalon rejects buyout, Valeant remains committed

Wednesday, April 6, 2011 11:52 AM

U.S.-based Cephalon has rejected Canadian-based Valeant Pharmaceuticals International's takeover bid, saying that the $5.7 billion offer, or $73.00 per share, is not in the best interests of shareholders, according to Pharma Times.

More... »

CRF Health – eCOA Forum

Pension fund sues Cephalon over Valeant buyout

Friday, April 1, 2011 01:54 PM

A Pennsylvania pension fund has filed a lawsuit and accused Cephalon officials of “failing to act” in the best interests of investors regarding a $5.7 billion buyout bid by rival Mississauga, Ontario-based Valeant Pharmaceuticals International, according to a Bloomberg report.

More... »

Valeant approaches Cephalon with buyout offer

Wednesday, March 30, 2011 01:55 PM

Valeant Pharmaceuticals International, based in Canada, has made an unsolicited bid to buy U.S.-based Cephalon, a biopharmaceutical company, for $5.7 billion.

More... »

Pearl Therapeutics appoints new president and CEO

Friday, March 11, 2011 11:33 AM

Pearl Therapeutics has named Chuck Bramlage president and chief executive officer. In addition, Mr. Bramlage will join the company's board of directors.

More... »

Lambda acquires Biovail’s early phase unit

Tuesday, August 10, 2010 07:32 AM

As part of transforming from a maker of primarily generic drugs to a maker of innovator products, and also as part of its impending merger with Aliso Viejo, Calif.-based Valeant, Toronto-based Biovail has sold its 194-bed, phase I/bioanalystics lab to Indian CRO Lambda Therapeutic Research for $6 million.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.